# Tenon Medical, Inc.: filings

TNON · Nasdaq · CIK 1560293 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tnon.md) · [Financials](/companies/tnon/financials.md) · [Filings](/companies/tnon/filings.md) · [Insiders](/companies/tnon/insiders.md)

## Reports and events: 105 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 57, 8-K 55, 3 15, 10-Q 14, EFFECT 14, CORRESP 12, D 12, S-1/A 11, UPLOAD 11, 424B3 9, S-1 9, 8-K/A 6, 424B5 5, DEF 14A 5, PRE 14A 5, 10-K 4, 424B4 4, DEFR14A 4, DRS 4, POS AM 4, S-3 4, S-3/A 4, S-8 4, SC 13G 4, 5 3, SC 13G/A 3, 8-A12B 2, CERT 2, DRS/A 2, DRSLTR 2, SCHEDULE 13G 2, ARS 1, D/A 1, DEL AM 1, RW 1, S-1MEF 1, SCHEDULE 13D 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 21:02 ET | [8-K](/filings/0001213900-26-111740.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-111740 |
| 2026-09-16 | 21:23 ET | [8-K](/filings/0001213900-26-100596.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100596 |
| 2026-09-09 | 12:45 ET | [8-K](/filings/0001213900-26-098232.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-098232 |
| 2026-08-31 | 19:40 ET | [8-K](/filings/0001213900-26-095686.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-095686 |
| 2026-08-26 | 19:30 ET | [8-K/A](/filings/0001213900-26-093926.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-093926 |
| 2026-08-24 | 17:23 ET | [8-K](/filings/0001213900-26-092944.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-092944 |
| 2026-08-13 | 21:20 ET | [10-Q](/filings/0001213900-26-089258.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089258 |
| 2026-08-13 | 20:25 ET | [8-K](/filings/0001213900-26-089138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-089138 |
| 2026-08-10 | 21:26 ET | [8-K](/filings/0001213900-26-087352.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-087352 |
| 2026-07-24 | 20:45 ET | [8-K](/filings/0001213900-26-081438.md) | 5.07 Shareholder vote results | 0001213900-26-081438 |
| 2026-07-20 | 12:15 ET | [8-K](/filings/0001213900-26-079415.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-079415 |
| 2026-07-10 | 21:19 ET | [8-K](/filings/0001213900-26-077274.md) | 8.01 Other events | 0001213900-26-077274 |
| 2026-07-02 | 20:05 ET | [8-K](/filings/0001213900-26-074953.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-074953 |
| 2026-06-26 | 15:45 ET | [S-1/A](/filings/0001213900-26-072460.md) | Registration statement, amended | 0001213900-26-072460 |
| 2026-06-23 | 10:11 ET | [DEF 14A](/filings/0001213900-26-070828.md) | Proxy statement, period 2026-07-23 | 0001213900-26-070828 |
| 2026-06-22 | 21:15 ET | [S-1](/filings/0001213900-26-070685.md) | Registration statement | 0001213900-26-070685 |
| 2026-06-12 | 21:20 ET | [8-K](/filings/0001213900-26-068390.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-068390 |
| 2026-06-11 | 20:05 ET | [8-K](/filings/0001213900-26-067819.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-067819 |
| 2026-05-22 | 21:15 ET | [8-K](/filings/0001213900-26-060662.md) | 3.01 Delisting notice | 0001213900-26-060662 |
| 2026-05-15 | 20:02 ET | [10-Q](/filings/0001213900-26-057695.md) | Quarterly report, period 2026-03-31 | 0001213900-26-057695 |
| 2026-05-12 | 20:16 ET | [8-K](/filings/0001213900-26-055085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-055085 |
| 2026-03-27 | 21:15 ET | [10-K](/filings/0001213900-26-035707.md) | Annual report, period 2025-12-31 | 0001213900-26-035707 |
| 2026-03-19 | 20:10 ET | [8-K](/filings/0001213900-26-031840.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-031840 |
| 2026-03-17 | 00:03 ET | [8-K](/filings/0001213900-26-028569.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-028569 |
| 2026-02-27 | 21:30 ET | [8-K](/filings/0001213900-26-021682.md) | 3.01 Delisting notice | 0001213900-26-021682 |
| 2026-02-06 | 21:11 ET | [8-K](/filings/0001213900-26-013278.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-013278 |
| 2025-11-17 | 21:05 ET | [8-K](/filings/0001213900-25-111522.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-111522 |
| 2025-11-13 | 21:01 ET | [10-Q](/filings/0001213900-25-109961.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109961 |
| 2025-10-17 | 21:15 ET | [8-K/A](/filings/0001213900-25-100037.md) | 9.01 Financial statements and exhibits | 0001213900-25-100037 |
| 2025-10-16 | 20:45 ET | [8-K](/filings/0001213900-25-099596.md) | 3.02 Unregistered sale of equity | 0001213900-25-099596 |
| 2025-09-23 | 20:30 ET | [8-K](/filings/0001213900-25-090627.md) | 5.07 Shareholder vote results | 0001213900-25-090627 |
| 2025-08-13 | 20:05 ET | [10-Q](/filings/0001213900-25-075652.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075652 |
| 2025-08-08 | 19:44 ET | [SCHEDULE 13D](/filings/0002078467-25-000001.md) | Ownership report, active investor | 0002078467-25-000001 |
| 2025-08-07 | 01:44 ET | [8-K](/filings/0001213900-25-072781.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-072781 |
| 2025-06-17 | 23:17 ET | [DEF 14A](/filings/0001213900-25-054893.md) | Proxy statement, period 2025-07-23 | 0001213900-25-054893 |
| 2025-05-13 | 20:50 ET | [10-Q](/filings/0001213900-25-042714.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042714 |
| 2025-04-04 | 20:07 ET | [S-1](/filings/0001213900-25-029005.md) | Registration statement | 0001213900-25-029005 |
| 2025-03-28 | 21:04 ET | [8-K](/filings/0001013762-25-004228.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-25-004228 |
| 2025-03-27 | 20:00 ET | [8-K](/filings/0001013762-25-003341.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-25-003341 |
| 2025-03-26 | 20:25 ET | [10-K](/filings/0001013762-25-002734.md) | Annual report, period 2024-12-31 | 0001013762-25-002734 |
| 2025-03-12 | 21:28 ET | [8-K](/filings/0001213900-25-023304.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-023304 |
| 2024-11-14 | 21:00 ET | [10-Q](/filings/0001213900-24-098375.md) | Quarterly report, period 2024-09-30 | 0001213900-24-098375 |
| 2024-11-04 | 22:30 ET | [S-1/A](/filings/0001213900-24-094233.md) | Registration statement, amended | 0001213900-24-094233 |
| 2024-10-17 | 21:18 ET | [S-1](/filings/0001213900-24-088577.md) | Registration statement | 0001213900-24-088577 |
| 2024-10-04 | 21:59 ET | [8-K](/filings/0001213900-24-085131.md) | 3.01 Delisting notice | 0001213900-24-085131 |
| 2024-09-17 | 21:22 ET | [8-K](/filings/0001213900-24-079515.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-079515 |
| 2024-09-16 | 18:22 ET | [8-K](/filings/0001213900-24-078903.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-078903 |
| 2024-09-11 | 15:01 ET | [8-K](/filings/0001213900-24-077584.md) | 3.01 Delisting notice | 0001213900-24-077584 |
| 2024-09-10 | 00:02 ET | [8-K/A](/filings/0001213900-24-077047.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-077047 |
| 2024-09-09 | 20:37 ET | [S-1/A](/filings/0001213900-24-076960.md) | Registration statement, amended | 0001213900-24-076960 |

Page 1 of 3. [Older](/companies/tnon/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.